- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04244305
Endurance Training in Patients Undergoing Lung Transplantation
Endurance Training in Patients Undergoing Lung Transplantation: Differences Between Treadmill and Cycle Ergometry Training
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing lung transplantation at the Thoracic Surgery Unit of the Hospital Clínico Universitario de A Coruña.
- Adults > 18 years.
- Ability to attend post-surgery exercise training for a minimum period of one month.
- Sign informed consent.
Exclusion Criteria:
- Torpid post-operative recovery with a prolonged stay at the Post-Anaesthesia Care Unit > 12 days.
- Diagnosed with intensive care unit acquired muscle weakness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treadmill Training
Participants in the treadmill training group will perform endurance training during the post-operative period using a treadmill (Salter Housewares, UK) for a minimum of 20 sessions. Intensity of training will be set according to 80% of the mean speed achieved during the 6MWT for a targeted time of 30 minutes. Intensity and duration will be adapted to the participant's physical condition, especially during the first week. After the endurance training, participants will perform resistance training for 20 - 30 minutes for conditioning of the main muscles in the upper and lower limbs using elastic bands, dumbbells and body-weight exercises. Intensity will progressively increase up to 70% of the maximum isometric strength measured with a hand-held dynamometer. Volume of training will also increase from 1 to 3 sets of 12 repetitions each. When needed patients will also be taught breathing exercises and airway clearance techniques. |
Endurance training in the form of treadmill/cycle-ergometry
|
|
Active Comparator: Cyclo-ergometry Training
Participants in this group will perfom endurance training during the post-operative period using a cycle ergometer (Monark 828e, Monark AB, Sweeden) for a minimum of 20 sessions.
Intensity of training will be set according to the results of a symptom-limited incremental cycle-ergometry test performed on the first day to achieve 80% of the maximal workload obtained for a targeted time of 30 minutes.
Intensity and duration will be adapted to the participant's physical condition, especially during the first week.
Participants in this group will also perfom resistance training and breathing exercises as in the treadmill training group.
|
Endurance training in the form of treadmill/cycle-ergometry
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6 Minute Walk Test
Time Frame: 1 month
|
Distance covered during the 6 Minute Walk Test performed according to the American Thoracic Guidelines.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6 Minute Walk Test
Time Frame: 3 Months
|
Distance covered with the 6 Minute Walk Test performed according to the American Thoracic Guidelines.
|
3 Months
|
|
Maximal isometric strength
Time Frame: 1 and 3 months
|
Isometrical maximal strength of the brachial biceps and quadriceps muscle of both dominant and non-dominant limbs.
Maximal isometric strength will be assessed using a hand-held dynamometer (Lafayette Instrument, Model 01165) and will be presented in kilograms
|
1 and 3 months
|
|
Sit-to-stand
Time Frame: 1 and 3 months
|
Number of times the patient can stand up from a chair and sit back in 30 seconds
|
1 and 3 months
|
|
Forced Expiratory Volume 1st second (FEV1)
Time Frame: 1 and 3 months
|
Changes in Forced Expiratory Volume in the 1st second assessed during a forced spirometry test performed according to the international guidelines.
|
1 and 3 months
|
|
Incremental Symptom-Limited Test
Time Frame: 1 and 3 months
|
Incremental symptom-limited test performed on a cycle-ergometry with a 5-10W increase per minute up to maximal tolerance.
Patient was monitorised during the test for both heart rate and oxygen saturation.
|
1 and 3 months
|
|
Maximal inspiratory and expiratory pressures
Time Frame: 1 and 3 months
|
Maximal inspiratory and expiratory pressures performed with the respiratory muscles
|
1 and 3 months
|
|
Forced Expiratory Capacity (FVC)
Time Frame: 1 and 3 months
|
Changes in forced expiratory capacity assessed during a forced spirometry test performed according to the international guidelines.
|
1 and 3 months
|
|
Peak Expiratory Flow (PEF)
Time Frame: 1 and 3 months
|
Changes in peak expiratory flow assessed during a forced spirometry test performed according to the international guidelines.
|
1 and 3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EGM-TXP-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Transplantation
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Germany, Italy, Poland, United Kingdom, Czechia, France
-
Emory UniversityCompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Heart-Lung TransplantationUnited States
-
Astellas Pharma IncCompletedHeart Transplantation | Lung Transplantation | Pancreas (Including SPK) TransplantationFrance, United Kingdom, Taiwan, Belgium, Italy, Austria
-
Hannover Medical SchoolUnknownExercise Training | Lung Transplantation | Psychotherapy | Heart-Lung Transplantation | "Rehabilitation"Germany
-
The First Affiliated Hospital of Guangzhou Medical...Completed
-
Hannover Medical SchoolTerminatedLung TransplantationGermany
-
XVIVO PerfusionCompletedLung TransplantationCanada
-
Philipps University MarburgCompletedTransplantation LungAustria, Germany
-
Ludwig-Maximilians - University of MunichCompletedLung TransplantationGermany
-
Novartis PharmaceuticalsCompleted
Clinical Trials on Exercise Therapy
-
University Hospital, GhentCompletedInsertional Achilles TendinopathyBelgium
-
Norwegian University of Science and TechnologyCompletedPatellofemoral Pain Syndrome
-
Istanbul Physical Medicine Rehabilitation Training...Completedthe Effect of Virtual Reality on Stroke Rehabilitation
-
Proaxis TherapyVirginia Commonwealth University; Arcadia University; National Athletic Trainers...CompletedShoulder Impingement SyndromeUnited States
-
Taipei Medical UniversityNot yet recruiting
-
Royal College of Surgeons, IrelandUnknownHip OsteoarthritisIreland
-
University Hospital, GhentCompletedAchilles TendinopathyBelgium
-
Gazi UniversityCompletedTemporomandibular DisorderTurkey
-
George Washington UniversityCompletedPrematurityUnited States
-
Medipol UniversityCompletedHemiplegia | Gait, Hemiplegic | Motor Function | Balance; DistortedTurkey